SCHEMBL4083512

SCHEMBL4083512

C[Si](C)(C)CCOCn1c(Cc2ccccc2)nc(-c2ccc(Cl)cc2)c1-c1ccc(Cl)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F11 P03951 1/20 0.42
AKR1B10 O60218 3/20 0.42
GAA P10253 4/20 0.40
ALDH1A1 P00352 3/20 0.40
HTT P42858 4/20 0.40
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
NPSR1 Q6W5P4 3/20 0.38
LMNA P02545 5/20 0.37
DRD2 P14416 1/20 0.36
TBXA2R P21731 1/20 0.36
TP53 P04637 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
KDM4E B2RXH2 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
MEN1 O00255 3/20 0.36
KMT2A Q03164 3/20 0.36
MAPT P10636 2/20 0.36
USP2 O75604 1/20 0.35
PTGDR2 Q9Y5Y4 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7047749 0.84 ALDH1A1 (0.42) F11ALDH1A1NPSR1TP53MEN1
SCHEMBL4076184 0.79 DGAT1 (0.46) F11NPSR1KDM4EMEN1KMT2A
SCHEMBL2846531 0.76 FAAH (0.43) F11NPC1LMNADRD2TBXA2R
SCHEMBL9370452 0.75 FAAH (0.41) F11ALDH1A1NPC1KDM4E
SCHEMBL4069849 0.74 F11 (0.39) F11ALDH1A1NPC1NPSR1LMNA
SCHEMBL7041230 0.74 NPSR1 (0.44) F11ALDH1A1NPSR1LMNADRD2
SCHEMBL2840916 0.73 FAAH (0.53) F11GAAALDH1A1NPC1KDM4E
SCHEMBL9525207 0.73 MAPK14 (0.43) F11ALDH1A1NPC1LMNAKDM4E
SCHEMBL9526288 0.71 F11 (0.36) F11ALDH1A1NPC1NPSR1LMNA
SCHEMBL9369648 0.71 FAAH (0.40)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7572785-B2 Substituted imidazoles as cannabinoid receptor modulators MERCK & CO., INC. (US) 2009-08-11 US disclosed
US-7057051-B2 Substituted imidazoles as cannabinoid receptor modulators MERCK & CO., INC. (US) 2006-06-06 US disclosed
US-20060089356-A1 Substituted imidazoles as cannabinoid receptor modulators MERCK SHARP & DOHME CORP. 2006-04-27 US disclosed
US-20030114495-A1 Substituted imidazoles as cannabinoid receptor modulators MERCK SHARP & DOHME CORP. 2003-06-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060089356-A1 Substituted imidazoles as cannabinoid receptor modulators CNR1, CNR2, GPR119 F11 1851/4885AKR1B10 4127/4885GAA 2453/4885
US-20030114495-A1 Substituted imidazoles as cannabinoid receptor modulators CNR1, CNR2, GPR119 F11 1851/4885AKR1B10 4127/4885GAA 2453/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.